TWO SIGMA INVESTMENTS, LP - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 26 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$19,197
+6.6%
12,149
-16.3%
0.00%
Q3 2022$18,000
-48.6%
14,518
-15.8%
0.00%
Q2 2022$35,000
-72.0%
17,249
-65.5%
0.00%
Q1 2022$125,000
-76.2%
50,068
-64.5%
0.00%
-100.0%
Q4 2021$525,000
+76.2%
140,857
+89.6%
0.00%0.0%
Q3 2021$298,00074,2800.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 275,000$1,103,0000.40%
Manatuck Hill Partners, LLC 273,100$1,095,0000.38%
Stonepine Capital Management, LLC 165,775$665,0000.30%
Ikarian Capital, LLC 311,041$1,247,0000.09%
COOPERMAN LEON G 200,000$802,0000.04%
Jump Financial, LLC 18,300$73,0000.01%
Shay Capital LLC 10,000$40,0000.01%
Newbridge Financial Services Group, Inc. 1,510$6,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 30,904$124,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$5,0000.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders